ICU Medical acquired the former Abbott Laboratories Critical Care business from Hospira in 2009 following a four year business arrangement in which ICU acted as the manufacturer of the Hospira critical care product line.
The patent expired in the early 1980s; the FDA authorized the sale of several generic versions in the USA, including from manufacturers Bioniche Pharma, Baxter Healthcare, Sandoz, Akorn Strides and Hospira.
Hospira |